Does LANADELUMAB-FLYO Cause Poor venous access? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Poor venous access have been filed in association with LANADELUMAB-FLYO. This represents 1.1% of all adverse event reports for LANADELUMAB-FLYO.
17
Reports of Poor venous access with LANADELUMAB-FLYO
1.1%
of all LANADELUMAB-FLYO reports
0
Deaths
11
Hospitalizations
How Dangerous Is Poor venous access From LANADELUMAB-FLYO?
Of the 17 reports, 11 (64.7%) required hospitalization, and 3 (17.6%) were considered life-threatening.
Is Poor venous access Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LANADELUMAB-FLYO. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does LANADELUMAB-FLYO Cause?
Hereditary angioedema (794)
Product dose omission issue (177)
Inappropriate schedule of product administration (144)
Drug ineffective (137)
Headache (126)
Weight decreased (125)
Weight increased (120)
Injection site pain (119)
Product use issue (114)
Malaise (90)
What Other Drugs Cause Poor venous access?
VEDOLIZUMAB (1,043)
INFLIXIMAB (917)
INFLIXIMAB-DYYB (782)
ECULIZUMAB (555)
HUMAN IMMUNOGLOBULIN G (504)
NATALIZUMAB (422)
RITUXIMAB (299)
TOCILIZUMAB (287)
METHOTREXATE (257)
ABATACEPT (249)
Which LANADELUMAB-FLYO Alternatives Have Lower Poor venous access Risk?
LANADELUMAB-FLYO vs LANREOTIDE
LANADELUMAB-FLYO vs LANSOPRAZOLE
LANADELUMAB-FLYO vs LANTHANUM
LANADELUMAB-FLYO vs LANTUS
LANADELUMAB-FLYO vs LANTUS SOLOSTAR